Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Clin. Cancer Res 2020 Nov 30;[EPub Ahead of Print], J Kiyokawa, Y Kawamura, SM Ghouse, S Acar, E Barçın, J Martínez-Quintanilla, RL Martuza, R Alemany, SD Rabkin, K Shah, H WakimotoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.